Paper Details 
Original Abstract of the Article :
Alginate, a biopolymer is most useful for anticancer drug delivery, because of it is biocompatible, nontoxic, biodegradable and exploiting ligand-receptor interaction. Breast cancer is spreading very fast due to the changing food habits and environmental causes. Exemestane (EXE) an oral chemotherape...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.ijbiomac.2017.07.064

データ提供:米国国立医学図書館(NLM)

Exemestane-Loaded Alginate Nanoparticles: A New Oasis in the Desert of Breast Cancer Treatment

Breast cancer is a formidable foe, like a vast desert filled with hidden dangers. This study explores a novel approach to treating breast cancer using exemestane, an anticancer drug, encapsulated in alginate nanoparticles. The researchers found that these nanoparticles could effectively deliver the drug to cancer cells, potentially reducing side effects and improving treatment outcomes. It's like finding a new oasis in the desert, offering a safe and effective way to deliver medicine.

Nanoparticle Delivery: A Precision Strike Against Breast Cancer

The study highlights the potential of alginate nanoparticles to improve the delivery of exemestane, potentially enhancing its efficacy and reducing side effects. It's like finding a more accurate and targeted weapon to combat the desert of cancer cells.

A Promising Future for Breast Cancer Treatment

The study suggests that this nanoparticle-based drug delivery system could be a promising approach for treating breast cancer. It's like discovering a new oasis with a potential for a more effective and gentler treatment.

Dr.Camel's Conclusion

This research highlights the exciting potential of nanoparticle technology in delivering cancer drugs. It offers hope for improved treatment outcomes and reduced side effects, representing a significant step forward in the battle against breast cancer.

Date :
  1. Date Completed 2018-06-04
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

28711612

DOI: Digital Object Identifier

10.1016/j.ijbiomac.2017.07.064

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.